REG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
RNS Number : 1541LBank of America Merrill Lynch28 April 2020FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
Name of exempt principal trader
BofA Securities, Inc.
Company dealt in
AbbVie Inc
Class of relevant security to which the
dealings being disclosed relate(Note 1)Common - US00287Y1091
Date of dealing
27/04/2020
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 2)
Class of relevant security: Common
US00287Y1091
Long
Short
Number
%
Number
%
(1)
Relevant securities
204,482
0.014%
3,356,067
0.227 %
(2)
Derivatives (other than options):
2,562,053
0.173%
193,957
0.013%
(3)
Options and agreements to purchase/sell:
7,400
0.001%
7,500
0.001%
Total
2,773,935
0.188%
3,557,524
0.241%
(b)
Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
%
Number
%
(1)
Relevant securities
0
0%
0
0%
(2)
Derivatives (other than options):
0
0%
0
0%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3.
DEALINGS (Note 3)
(a)
Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
69
84.69 USD
Purchase
476
83.59 USD
Purchase
1
83.79 USD
Purchase
1
83.83 USD
Purchase
105
83.84 USD
Purchase
3
83.85 USD
Purchase
25
83.87 USD
Purchase
104
83.88 USD
Purchase
25
83.95 USD
Purchase
30
83.98 USD
Purchase
32
83.99 USD
Purchase
28
84 USD
Purchase
9
84.01 USD
Purchase
112
84.02 USD
Purchase
118
84.03 USD
Purchase
78
84.04 USD
Purchase
132
84.05 USD
Purchase
117
84.06 USD
Purchase
206
84.07 USD
Purchase
39
84.08 USD
Purchase
32
84.09 USD
Purchase
1
84.095 USD
Purchase
57
84.1 USD
Purchase
113
84.11 USD
Purchase
6
84.115 USD
Purchase
625
84.12 USD
Purchase
40
84.13 USD
Purchase
264
84.14 USD
Purchase
246
84.15 USD
Purchase
507
84.16 USD
Purchase
730
84.17 USD
Purchase
139
84.18 USD
Purchase
7
84.19 USD
Purchase
262
84.2 USD
Purchase
179
84.21 USD
Purchase
80
84.22 USD
Purchase
2,600
84.225 USD
Purchase
54
84.23 USD
Purchase
276
84.24 USD
Purchase
10
84.245 USD
Purchase
249
84.25 USD
Purchase
312
84.26 USD
Purchase
191
84.27 USD
Purchase
3
84.275 USD
Purchase
230
84.28 USD
Purchase
363
84.29 USD
Purchase
396
84.3 USD
Purchase
131
84.31 USD
Purchase
1,972
84.315 USD
Purchase
158
84.32 USD
Purchase
44
84.325 USD
Purchase
178
84.33 USD
Purchase
152
84.34 USD
Purchase
116
84.35 USD
Purchase
266
84.353 USD
Purchase
119
84.36 USD
Purchase
303
84.37 USD
Purchase
423
84.38 USD
Purchase
137
84.39 USD
Purchase
2,308
84.4 USD
Purchase
16
84.405 USD
Purchase
41
84.41 USD
Purchase
10
84.42 USD
Purchase
12
84.43 USD
Purchase
34
84.44 USD
Purchase
73
84.45 USD
Purchase
86
84.46 USD
Purchase
110
84.47 USD
Purchase
107
84.48 USD
Purchase
100
84.49 USD
Purchase
29
84.5 USD
Purchase
1
84.515 USD
Purchase
103
84.52 USD
Purchase
100
84.525 USD
Purchase
33
84.53 USD
Purchase
132
84.535 USD
Purchase
418
84.54 USD
Purchase
27
84.55 USD
Purchase
63
84.56 USD
Purchase
273
84.57 USD
Purchase
101
84.575 USD
Purchase
556
84.58 USD
Purchase
418
84.59 USD
Purchase
432
84.6 USD
Purchase
4
84.605 USD
Purchase
104
84.61 USD
Purchase
281
84.62 USD
Purchase
184
84.63 USD
Purchase
224
84.64 USD
Purchase
504
84.65 USD
Purchase
1,833
84.66 USD
Purchase
2,748
84.67 USD
Purchase
100
84.675 USD
Purchase
829
84.68 USD
Purchase
307,966
84.69 USD
Purchase
700
84.7 USD
Purchase
1,119
84.71 USD
Purchase
458
84.72 USD
Purchase
600
84.73 USD
Purchase
403
84.74 USD
Purchase
316
84.75 USD
Purchase
236
84.76 USD
Purchase
54
84.77 USD
Purchase
14
84.78 USD
Purchase
40
84.8 USD
Purchase
100
84.81 USD
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Sale
476
83.59 USD
Sale
20
83.89 USD
Sale
203
83.97 USD
Sale
257
83.98 USD
Sale
303
83.99 USD
Sale
1
84 USD
Sale
24
84.03 USD
Sale
11
84.04 USD
Sale
21
84.06 USD
Sale
12
84.12 USD
Sale
12
84.16 USD
Sale
10
84.17 USD
Sale
10
84.19 USD
Sale
13
84.2 USD
Sale
24
84.21 USD
Sale
17
84.22 USD
Sale
32
84.23 USD
Sale
23
84.24 USD
Sale
12
84.26 USD
Sale
27
84.28 USD
Sale
31
84.29 USD
Sale
20
84.3 USD
Sale
7
84.31 USD
Sale
2
84.32 USD
Sale
23
84.33 USD
Sale
22
84.34 USD
Sale
32
84.37 USD
Sale
32
84.39 USD
Sale
3
84.4 USD
Sale
12
84.41 USD
Sale
12
84.47 USD
Sale
25
84.49 USD
Sale
25
84.53 USD
Sale
84
84.56 USD
Sale
66
84.57 USD
Sale
25
84.58 USD
Sale
19
84.6 USD
Sale
25
84.62 USD
Sale
13
84.625 USD
Sale
20
84.635 USD
Sale
43
84.66 USD
Sale
19
84.67 USD
Sale
59
84.68 USD
Sale
889,145
84.69 USD
Sale
25
84.7 USD
Sale
25
84.74 USD
Sale
21,912
84.69 USD
(b)
Derivatives transactions (other than options transactions)
Product name,
e.g. CFDNature of transaction
(Note 5)Number of relevant securities
(Note 6)Price per unit
(Note 4)Swaps
Reducing a Long Position
598
84.69 USD
Swaps
Reducing a Long Position
1,135
84.69 USD
Swaps
Reducing a Long Position
107
84.69 USD
Swaps
Reducing a Long Position
13,718
84.69 USD
Swaps
Reducing a Long Position
1,044
84.69 USD
Swaps
Reducing a Long Position
10,727
84.69 USD
Swaps
Reducing a Long Position
12
84.69 USD
Swaps
Closing a Long Position
235
84.69 USD
Swaps
Reducing a Long Position
96
84.69 USD
Swaps
Reducing a Long Position
35
84.69 USD
Swaps
Reducing a Long Position
622
84.69 USD
Swaps
Reducing a Long Position
65
84.69 USD
Swaps
Reducing a Long Position
5,958
84.69 USD
Swaps
Reducing a Long Position
404
84.69 USD
Swaps
Increasing a Long Position
600,000
84.69 USD
Swaps
Increasing a Short Position
266
84.36 USD
Swaps
Reducing a Long Position
160
84.69 USD
Swaps
Reducing a Long Position
2,451
84.69 USD
Swaps
Reducing a Long Position
98
84.69 USD
Swaps
Opening a Short Position
55,847
84.69 USD
Swaps
Reducing a Long Position
3,328
84.69 USD
Swaps
Reducing a Long Position
391
84.69 USD
Swaps
Reducing a Long Position
15,004
84.69 USD
Swaps
Reducing a Long Position
353
84.69 USD
Swaps
Reducing a Long Position
532
84.69 USD
Swaps
Reducing a Long Position
932
84.69 USD
Swaps
Reducing a Long Position
2,521
84.69 USD
Swaps
Reducing a Long Position
2,354
84.69 USD
Swaps
Reducing a Long Position
1,128
84.69 USD
Swaps
Reducing a Long Position
260
84.69 USD
Swaps
Reducing a Long Position
62,480
84.69 USD
Swaps
Reducing a Long Position
44
84.325 USD
Swaps
Reducing a Long Position
80,285
84.69 USD
Swaps
Reducing a Long Position
9
84.69 USD
Swaps
Reducing a Long Position
1,006
84.69 USD
Swaps
Reducing a Long Position
38
84.69 USD
Swaps
Reducing a Long Position
259
84.69 USD
Swaps
Reducing a Long Position
10,198
84.69 USD
Swaps
Reducing a Long Position
2,070
84.69 USD
Swaps
Reducing a Long Position
22
84.69 USD
Swaps
Reducing a Long Position
600
84.69 USD
Swaps
Reducing a Long Position
1,125
84.69 USD
Swaps
Reducing a Long Position
1,299
84.69 USD
Swaps
Reducing a Long Position
2,717
84.69 USD
Swaps
Reducing a Long Position
4,214
84.69 USD
Swaps
Reducing a Long Position
538
84.69 USD
Swaps
Reducing a Long Position
77
84.69 USD
(c)
Options transactions in respect of existing relevant securities
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call optionNumber of securities
Exercise price per
unit (Note 4)N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)Details
Price per unit
(if applicable) (Note 4)
Borrow
Borrow of 99,323 shares
N/A
Borrow
Borrow of 87,500 shares
N/A
Borrow
Borrow of 325,000 shares
N/A
Borrow
Borrow of 300,700 shares
N/A
Borrow
Borrow of 17,200 shares
N/A
Borrow
Borrow of 98,400 shares
N/A
Borrow
Borrow of 130,000 shares
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.None
Is a Supplemental Form 38.5(b) attached? (Note 8)
Yes
Date of disclosure
28/04/2020
Contact name
Tolu Tade
Telephone number
+44207 996 3410
Name of offeree/offeror with which connected
AbbVie Inc
Nature of connection (Note 9)
Advisor to - AbbVie Inc
SUPPLEMENTAL FORM 38.5(b)
DISCLOSURE UNDER RULE 38.5 (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
Product name,
e.g. call optionWritten or
purchasedNumber of securities to which the option or derivative relates
Exercise price
(Note 2)Type, e.g.
American,
European etcExpiry date
Call Option
Written
7,500
105 USD
American
15/01/2021
Call Option
Purchased
7,400
85 USD
American
15/01/2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDISEFIFVASTITFII
Recent news on Abbvie
See all newsRCS - Ripple Therapeutics - Ripple Therapeutics Announces Collaboration
AnnouncementREG - Stock Exch Notice - Admission to ISM - 20/06/2024
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
Announcement